01 Growing Adoption of Disease-Specific Medical Nutrition Products The Medical Nutrition market trends are being driven by the increasing prevalence of chronic diseases, an aging global population, and greater awareness of nutrition as part of clinical treatment. These specialized formulations help improve recovery, reduce hospital stays, and support long-term disease management. In February 2025, the European Society for Clinical Nutrition and Metabolism (ESPEN) reinforced the importance of early nutritional screening and individualized medical nutrition therapy in clinical practice through updated guidance and scientific discussions, encouraging broader adoption of specialized nutritional interventions across healthcare settings. Such developments are strengthening the role of medical nutrition in modern patient care.
02 Increasing Innovation in Personalized and High-Protein Clinical Nutrition Another important Medical Nutrition market trend is the development of personalized nutritional solutions tailored to individual health conditions, age, and recovery needs. Manufacturers are introducing high-protein, immune-supporting, and microbiome-focused formulations enriched with vitamins, minerals, omega-3 fatty acids, and probiotics. Digital health technologies are also being integrated to monitor nutritional status and improve treatment adherence. For instance, in 2025, Danone expanded its specialized nutrition portfolio with new medical nutrition products designed to support patients with disease-related malnutrition and age-related health conditions in multiple international markets. These product innovations, combined with increasing clinical awareness of nutrition's role in disease management, are accelerating innovation and supporting sustained growth in the Medical Nutrition market.
June 17, 2026 – Danone announced the completion of its acquisition of Kate Farms, a U.S.-based producer of plant-based medical and specialized nutrition products. The acquisition strengthens Danone’s Medical Nutrition portfolio and expands its offerings for patients requiring enteral and oral nutritional support.
May 2026 – Nestlé Health Science introduced new science-based nutritional solutions designed to support individuals using GLP-1 receptor agonist therapies. The expanded portfolio focuses on preserving muscle mass, improving protein intake, and addressing nutritional needs associated with weight management treatments.
March 2026 – Abbott announced the expansion of its Ensure® medical nutrition portfolio with new high-protein formulations aimed at supporting recovery, healthy aging, and disease-related malnutrition. The products are intended for use in hospitals, long-term care facilities, and home healthcare settings.
September 2025 – Danone announced the expansion of its medical nutrition manufacturing capacity through the opening of a new production line dedicated to specialized nutritional products for patients with chronic diseases and clinical nutrition requirements. The investment enhances supply capabilities across European markets.